BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ical.marudot.com//iCal Event Maker
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Toronto
LAST-MODIFIED:20250410T142247Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/America/Toronto
X-LIC-LOCATION:America/Toronto
BEGIN:DAYLIGHT
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20260106T161633Z
UID:1701988327970-26681@ical.marudot.com
DTSTART;TZID=America/Toronto:20260126T090000
DTEND;TZID=America/Toronto:20260126T103000
SUMMARY:OICR Mondays | “Advances in Bladder Cancer Research”
URL:https://oicr-ca.zoom.us/j/84257989948?pwd=yfe2HSAl5NEGLgpFCdwIlJsVHZbP4e.1 
DESCRIPTION:OICR Mondays | "How OICR and FACIT accelerate cancer solutions in Ontario"\n\nDate: Monday January 26\, 2026\nTime: 9 - 10:30 a.m. \n\nModerator: \n- Dr. Michelle Brazas\, Director\, OICR\n\nPanelists:\n- Adaptive Oncology: Dr. Lincoln Stein\, Acting Scientific Director and Head\, Adaptive Oncology\, OICR\n- Therapeutic Innovation: Dr. David Uehling\, Interim Scientific Lead\, Therapeutic Innovation and Drug Discovery\, OICR\n- Clinical Translation: Dr. David Cescon\, Clinician Scientist at University Health Network and Scientific Director\, Clinical Translation\, OICR\n- FACIT (TBD)\n- Patient Partner (TBD)\n\nJoin Zoom Meeting: https://oicr-ca.zoom.us/j/84257989948?pwd=yfe2HSAl5NEGLgpFCdwIlJsVHZbP4e.1 \n\nMeeting ID: 842 5798 9948\nPassword: 984134\nDate: Monday\, November 10\, 2025\nTime: 3:30 - 5 p.m.\n\nModerator: \n\n- Dr. David Berman\, Queen’s University\n\nSpeakers and presentations:\n\n- Quantitative bladder to improve non-muscle invasive bladder cancer management: Evelyn Yach & Taylor Zhang\, Queen’s University\n\n- Development of a therapeutic approach to target aging associated immune exhaustion in high-risk bladder cancer: Dr. Madhuri Koti\, Queen’s University\n\n- WOO Trial: Neoadjuvant Immune-Modulating Radiation with Durvalumab prior to Radical Cystectomy in Patients With Muscle-Invasive Bladder Carcinoma: Dr. Michael Ong\, The Ottawa Hospital\n\nZoom link:\nhttps://oicr-ca.zoom.us/j/86521194870?pwd=VLQyAzpFobBw4U5vZaYSaBT258OKTj.1&from=addon\n\nMeeting ID: 865 2119 4870\nPassword: 080976
LOCATION:Zoom Webinar
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:OICR Mondays | “Advances in Bladder Cancer Research”
TRIGGER:-PT1H
END:VALARM
END:VEVENT
END:VCALENDAR